PPARG and diabetes mellitus: Some glycosidic compounds prevent diabetes by targeting the sodium-dependent glucose cotransporter (SGLT), dipeptidyl peptidase IV (DPP-IV), glucagon-like peptide 1 (GLP1), and peroxisome proliferator-activated receptor gamma (PPARγ) [30].